Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

@article{DinisOliveira2017MetabolismOP,
  title={Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance},
  author={R. Dinis-Oliveira},
  journal={Drug Metabolism Reviews},
  year={2017},
  volume={49},
  pages={84 - 91}
}
  • R. Dinis-Oliveira
  • Published 2017
  • Medicine, Chemistry
  • Drug Metabolism Reviews
  • Abstract Psilocybin and psilocin are controlled substances in many countries. These are the two main hallucinogenic compounds of the “magic mushrooms” and both act as agonists or partial agonists at 5-hydroxytryptamine (5-HT)2A subtype receptors. During the last few years, psilocybin and psilocin have gained therapeutic relevance but considerable physiological variability between individuals that can influence dose-response and toxicological profile has been reported. This review aims to… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 75 REFERENCES
    Psilocybin – Summary of knowledge and new perspectives
    • 74
    • Open Access
    Detection of psilocin in body fluids.
    • 52
    • Open Access
    The pharmacology of psilocybin
    • 158
    • Open Access
    Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
    • 128
    Comparison of psilocin with psilocybin, mescaline and LSD-25
    • 52
    • Highly Influential
    Comparison of the reactions induced by psilocybin and LSD-25 in man
    • 62
    Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.
    • 50
    • Highly Influential
    • Open Access
    Psilocybin for treating substance use disorders?
    • 14
    • Open Access
    Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom".
    • 33
    • Open Access